Is bioMérieux S.A. (BMXMF) a Buy, Sell, or Hold?
OTC : BMXMF
bioMérieux S.A.
$80.66 USD
$0 (0.0%)
- Volume
- 66
- Average Volume
- 227
- Market Capitalization
- $9.52B
- P/E Ratio
- 21.54
- Dividend Yield
- 1.35%
- Price Target
- Year High
- $152.00
- Year Low
- $77.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.27
- Current Ratio
- $2.39
Company Overview
OTC
Pierre Boulud
Medical - Diagnostics & Research
Healthcare
BMXMF
14147
FR
USD
Liquidity Metrics
0.11
2.39
1.48
0.54
0.27
Sales & Valuation
$4.07B
2.10
2.08
18.91
3.85
Profitability
$3.34
$397.35M
9.76%
12.91%
9.89%
7.13%
P/E Metrics
21.54
-2.64
-2.64
Analyst Price Target & Rating
3/5
5 Analysts
%
Poll Results
No votes yet today — be the first to share your view!
About bioMérieux S.A. (OTC:BMXMF) Stock
Operating on a global scale, bioMérieux S.A. designs and produces in vitro diagnostic solutions specifically for detecting infectious diseases across the Americas, Europe, the Middle East, Africa, and Asia Pacific. The firm's offerings encompass diagnostic systems that analyze biological samples to identify infectious diseases, cardiovascular conditions, and various types of cancer. Furthermore, it provides essential microbiological testing for quality assurance within the food, pharmaceutical, cosmetics, and veterinary industries. Its diverse clientele includes clinical and hospital laboratories, medical professionals, blood banks, and industrial control facilities. Founded in 1963, initially under the name B-D Mérieux, bioMérieux S.A. is headquartered in Marcy l'Etoile, France, and funct ... ions as a subsidiary of Institut Mérieux SA.
bioMérieux S.A. (BMXXY) Q1 2026 Sales/Trading Call Transcript
2026-04-23 11:31:35
bioMérieux S.A. (BMXXY) Q1 2026 Sales/Trading Call Transcript
Analyzing HealthEquity (NASDAQ:HQY) and bioMerieux (OTCMKTS:BMXMF)
2026-04-21 03:21:02
HealthEquity (NASDAQ: HQY - Get Free Report) and bioMerieux (OTCMKTS:BMXMF - Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, risk, valuation, profitability, institutional ownership and dividends. Institutional and Insider Ownership 99.6% of HealthEquity shares are held
Frequently Asked Questions
-
What is the current bioMérieux S.A. (BMXMF) stock price?
-
bioMérieux S.A.(OTC:BMXMF) stock price is $80.66 in the last trading session. During the trading session, BMXMF stock reached the peak price of $152 while $77 was the lowest point it dropped to. The percentage change in BMXMF stock occurred in the recent session was 0.0% while the dollar amount for the price change in BMXMF stock was $0.
-
BMXMF's industry and sector of operation?
-
The OTC listed BMXMF is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector.
-
Who are the executives of BMXMF?
-
Guillaume Bouhours | Executive VP of Finance, Purchasing and Information Systems & CFO
Valerie Leylde | Executive Vice President of Human Resources, Communications & CSR
Charles K. Cooper | Executive VP of Medical Affairs & Chief Medical Officer
Frederic Beseme | Head of CSR
Pierre Boulud | Chief Executive Officer -
How many employees does BMXMF have?
-
Number of BMXMF employees currently stands at 14147. BMXMF operates from 376 Chemin De l’Orme, Marcy l'Étoile, ARA 69280, FR.
-
Link for BMXMF official website?
-
Official Website of BMXMF is: https://www.biomerieux.com
-
How do I contact BMXMF?
-
BMXMF could be contacted at phone #33 4 78 87 20 00 and can also be accessed through its website. BMXMF operates from 376 Chemin De l’Orme, Marcy l'Étoile, ARA 69280, FR.
-
How many shares of BMXMF are traded daily?
-
The average number of BMXMF shares traded daily for last 3 months was 227.
-
What is the market cap of BMXMF currently?
-
The market value of BMXMF currently stands at $9.52B with its latest stock price at $80.66